HKB Technology Excellence Awards 2023 Winner: Insilico Medicine Hong Kong Limited
Frank Pun, Head of Hong Kong Office at Insilico Medicine Hong Kong Limited, discusses the company's groundbreaking application of advanced AI platforms in clinical-stage biotech, focusing on novel target discovery and molecular structure generation for drug development.
Their recent introduction of the Pharma.AI platform, accompanied by successful internal pipeline advancements to the clinical stage, earned them the AI - Pharmaceuticals award at the Hong Kong Business Technology Excellence Awards.
Commentary
The succession shift: Redesigning wealth structures for the next generation
2026 biotech playbook: Hong Kong at the centre of China’s globalisation
Navigating Hong Kong’s regulatory landscape: a challenging and rewarding endeavour